MARCHIGNOLI, FRANCESCA
MARCHIGNOLI, FRANCESCA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Personale esterno ed autonomi
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus
2024 Nugnes M.; Baldassarre M.; Ribichini D.; Tedesco D.; Capelli I.; Vetrano D.; Marchignoli F.; Brodosi L.; Pompili E.; Petroni M.L.; La Manna G.; Marchesini G.; Naldi M.; Bartolini M.
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study
2023 Caviglia, GP; Armandi, A; D'Ambrosio, R; Lampertico, P; Bianco, C; Valenti, L; Ciccioli, C; Pennisi, G; Petta, S; Brodosi, L; Petroni, ML; Marchignoli, F; Pironi, L; Sagripanti, A; Argenziano, ME; Svegliati-Baroni, G; Bugianesi, E
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome
2023 Brodosi, L; Stecchi, M; Osti, V; Guarneri, V; Genovese, M; Marchignoli, F; Mita, D; Zioutas, M; Petroni, ML; Pironi, L
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease
2022 Brodosi L.; Marchignoli F.; Marchesini G.; Petroni M.L.
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis
2021 Colosimo, Santo; Ravaioli, Federico; Petroni, Maria L; Brodosi, Lucia; Marchignoli, Francesca; Barbanti, Francesca A; Sasdelli, Anna S; Marchesini, Giulio; Pironi, Loris
Evidence-based medicine and the problem of healthy volunteers
2017 Marchesini, Giulio*; Marchignoli, Francesca; Petta, Salvatore
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs
2023 Petroni M.L.; Brodosi L.; Armandi A.; Marchignoli F.; Bugianesi E.; Marchesini G.
NASH: A glance at the landscape of pharmacological treatment
2016 Lucia Brodosi; Francesca Marchignoli; Maria Letizia Petroni; Giulio Marchesini
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges
2021 Petroni M.L.; Brodosi L.; Marchignoli F.; Sasdelli A.S.; Caraceni P.; Marchesini G.; Ravaioli F.
Obesity and NAFLD: Same problem?
2020 Brodosi L, Barbanti F, Petroni ML, Marchignoli F, Marchesini G.
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy
2022 Ravaioli, F.; Petroni, M.L.; Brodosi, L.; Leoni, L.; Marchignoli, F.; Osti, V.; Mita, D.; Bocedi, G.; Sacilotto, F.; Barbanti, F.A.; Marchesini, G.R.; Pironi, L.
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy
2022 Ravaioli, Federico; Petroni, Maria Letizia; Marchignoli, Francesca; Leoni, Laura; Bocedi, Giulia; Sacilotto, Federica; Osti, Valentino; Mita, Dorina; Barbanti, Francesca; Brodosi, Lucia; Reggiani, Giulio Marchesini; Pironi, Loris
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
2023 Brodosi L.; Stecchi M.; Marchignoli F.; Lucia E.; Magnani L.; Guarneri V.; Petroni M.L.; Marchesini G.; Pironi L.
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey
2023 Brodosi L.; Stecchi M.; Mita D.; Marchignoli F.; Guarneri V.; Agnelli G.; Osti V.; Perazza F.; Sacilotto F.; Pession A.; Pironi L.
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease?
2017 Mazzotti, Arianna; Caletti, Maria Turchese; Marchignoli, Francesca; Forlani, Giulia; Marchesini, Giulio*
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus | Nugnes M.; Baldassarre M.; Ribichini D.; Tedesco D.; Capelli I.; Vetrano D.; Marchignoli F.; Brod...osi L.; Pompili E.; Petroni M.L.; La Manna G.; Marchesini G.; Naldi M.; Bartolini M. | 2024-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-25-03168.pdf; Supplementary materials.docx |
| Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study | Caviglia, GP; Armandi, A; D'Ambrosio, R; Lampertico, P; Bianco, C; Valenti, L; Ciccioli, C; Penni...si, G; Petta, S; Brodosi, L; Petroni, ML; Marchignoli, F; Pironi, L; Sagripanti, A; Argenziano, ME; Svegliati-Baroni, G; Bugianesi, E | 2023-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome | Brodosi, L; Stecchi, M; Osti, V; Guarneri, V; Genovese, M; Marchignoli, F; Mita, D; Zioutas, M; P...etroni, ML; Pironi, L | 2023-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease | Brodosi L.; Marchignoli F.; Marchesini G.; Petroni M.L. | 2022-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.01 Articolo in rivista | - |
| Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis | Colosimo, Santo; Ravaioli, Federico; Petroni, Maria L; Brodosi, Lucia; Marchignoli, Francesca; Ba...rbanti, Francesca A; Sasdelli, Anna S; Marchesini, Giulio; Pironi, Loris | 2021-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | liv.14799-1-1.pdf; liv14799-sup-0001-tables1-s3.docx |
| Evidence-based medicine and the problem of healthy volunteers | Marchesini, Giulio*; Marchignoli, Francesca; Petta, Salvatore | 2017-01-01 | ANNALS OF HEPATOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs | Petroni M.L.; Brodosi L.; Armandi A.; Marchignoli F.; Bugianesi E.; Marchesini G. | 2023-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | 32_Brodosi et al_ WEBvsGruppi.pdf |
| NASH: A glance at the landscape of pharmacological treatment | Lucia Brodosi; Francesca Marchignoli; Maria Letizia Petroni; Giulio Marchesini | 2016-01-01 | ANNALS OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges | Petroni M.L.; Brodosi L.; Marchignoli F.; Sasdelli A.S.; Caraceni P.; Marchesini G.; Ravaioli F. | 2021-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | nutrients-13-02748.pdf |
| Obesity and NAFLD: Same problem? | Brodosi L, Barbanti F, Petroni ML, Marchignoli F, Marchesini G. | 2020-01-01 | - | Bugianesi Elisabetta | 2.01 Capitolo / saggio in libro | - |
| Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy | Ravaioli, F.; Petroni, M.L.; Brodosi, L.; Leoni, L.; Marchignoli, F.; Osti, V.; Mita, D.; Bocedi,... G.; Sacilotto, F.; Barbanti, F.A.; Marchesini, G.R.; Pironi, L. | 2022-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy | Ravaioli, Federico; Petroni, Maria Letizia; Marchignoli, Francesca; Leoni, Laura; Bocedi, Giulia;... Sacilotto, Federica; Osti, Valentino; Mita, Dorina; Barbanti, Francesca; Brodosi, Lucia; Reggiani, Giulio Marchesini; Pironi, Loris | 2022-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease | Brodosi L.; Stecchi M.; Marchignoli F.; Lucia E.; Magnani L.; Guarneri V.; Petroni M.L.; Marchesi...ni G.; Pironi L. | 2023-01-01 | EATING AND WEIGHT DISORDERS | - | 1.01 Articolo in rivista | 36_Brodosi_BES-NASH.pdf |
| Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey | Brodosi L.; Stecchi M.; Mita D.; Marchignoli F.; Guarneri V.; Agnelli G.; Osti V.; Perazza F.; Sa...cilotto F.; Pession A.; Pironi L. | 2023-01-01 | ORPHANET JOURNAL OF RARE DISEASES | - | 1.01 Articolo in rivista | - |
| Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? | Mazzotti, Arianna; Caletti, Maria Turchese; Marchignoli, Francesca; Forlani, Giulia; Marchesini, ...Giulio* | 2017-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |